Summary The growth kinetics of established human colorectal tumour cell lines (HT29, HTI 15 and COLO 320DM) and human diploid fibroblasts (Flow 2002) were studied in conventional culture and in microcapsules formed from alginate -poly(L-lysine) - (Fidler, 1978) and the xenografting of human tumors into immunodeficient mice (Schmidt et al., 1977 (Darquy & Reach, 1985) . Recently the use of the microencapsulation technology in cancer therapeutic studies using established human tumour cell lines grown in immunocompetent animals has been reported (Gorelick et al., 1987; Chen et al., 1988 Lim and Sun (1980) based on considerations of the permeability of the microcapsular membrane (Shimi et al., 1991) was used. Briefly, the cells were harvested, centrifuged at 1000 g for 10 min, washed three times in phosphate buffered saline and resuspended at a final concentration of 2 x 106 ml-in 1.8% (w/v) sodium alginate. The suspension was then syringe-extruded through the central needle of a co-axial needle assembly in which air flowing through the peripheral needle sheared droplets of the mixture at a specified diameter. These were collected in a solution of calcium chloride in which they formed gel spheres of calcium alginate. The surface of these spheres was electrocomplexed with the polycation poly(L-lysine) of mean M, 22,000 thus forming the semi-permeable membrane. The remaining cationic charges on the surface of the spheres were neutralised by a further coating with alginate and the interior gel matrix of the microcapsules was then dissolved by chelating the calcium ions in citrate. The capsules were washed
Current methods for the experimental study of human cancer and its therapy involve the use of either tissue culture techniques in vitro or animal models (Bateman et al., 1979) such as the syngeneic tumour/animal system (Fidler, 1978) and the xenografting of human tumors into immunodeficient mice (Schmidt et al., 1977) . All these systems have important limitations in the prediction of the response of human tumours to therapeutic intervention (Bailey et al., 1981; Giovanella et al., 1983; Selby et al., 1983; Edelstein et al., 1984) , for instance the frequent difficulty encountered in culturing tumour cells free from stromal cells, the poor accessibility to manipulation of cultures growing in semi-solid media and the slow rate with which many tumours grow in nu/nu mice. While comparable with growth in the human host, this rate is too slow for predictive testing, since it may take 2-3 weeks before palpable tumour growth can be detected at all.
The encapsulation of mammalian cells within alginatepoly(L-lysine) -alginate membranes was first proposed by Chang (Chang et al., 1966) . Islets of Langerhans have been successfully microencapsulated and used as allografts (Sun & O'Shea, 1985) and as xenografts (O'Shea & Sun, 1986) to alleviate diabetes and its complications in recipient animals. The ability of the microcapsular membrane to immunoisolate xenografted cells has also been demonstrated (Darquy & Reach, 1985) . Recently the use of the microencapsulation technology in cancer therapeutic studies using established human tumour cell lines grown in immunocompetent animals has been reported (Gorelick et al., 1987; Chen et al., 1988 Lim and Sun (1980) based on considerations of the permeability of the microcapsular membrane (Shimi et al., 1991) was used. Briefly, the cells were harvested, centrifuged at 1000 g for 10 min, washed three times in phosphate buffered saline and resuspended at a final concentration of 2 x 106 ml-in 1.8% (w/v) sodium alginate. The suspension was then syringe-extruded through the central needle of a co-axial needle assembly in which air flowing through the peripheral needle sheared droplets of the mixture at a specified diameter. These were collected in a solution of calcium chloride in which they formed gel spheres of calcium alginate. The surface of these spheres was electrocomplexed with the polycation poly(L-lysine) of mean M, 22,000 thus forming the semi-permeable membrane. The remaining cationic charges on the surface of the spheres were neutralised by a further coating with alginate and the interior gel matrix of the microcapsules was then dissolved by chelating the calcium ions in citrate. The capsules were washed thoroughly in normal saline, their sedimented volume was estimated and they were placed in 10 volumes of culture medium.
Microcapsule disruption
Microcapsules were transferred to a motor-driven glass/glass Potter homogeniser and disrupted with three strokes of the pestle.
Growth kinetics (i) Monolayer or suspension culture Adherent lines were cultivated in 24-well plastic plates. Half of the medium was removed every 3 days and replaced by an equal amount of fresh medium. Duplicate samples were harvested by trypsin/ EDTA treatment at intervals for up to 30 days. Cell suspensions were diluted into counting medium and counted in a model D Coulter counter (which was calibrated daily with dextran beads and for each cell line by reference to calibration curves generated by parallel haemocytometer estimations). COLO 320DM cells were grown in 75 cm2 T-flasks and half of the medium was replaced every 3 days. Duplicate 2 ml samples of the cell suspension were removed after gentle shaking of the flask, added to 100 ml counting fluid and Coulter counted.
(ii) Microcapsules Following encapsulation, cell lines were cultured as 10% (packed volume of capsules:volume of medium) suspensions in nutrient medium in 75 cm2 flasks. Half of the medium was replaced every 3 days. Duplicate 1.0 ml samples of resuspended capsules were taken, the capsules were disrupted as described above and the homogenate was diluted to 100ml for Coulter counting.
Growth morphology
The microcapsules and conventional cultures were observed by phase-contrast microscopy prior to counting. Photographs were taken on an Olympus CK2 microscope fitted with a x 4 phase-contrast objective, a x 3.3 phototube and a Canon 35 mm camera body. 
Results

Growth kinetics
The initial seeding densities and important growth parameters are summarised in In contrast, microencapsulation of the anchorage-independent colorectal tumour line COLO 320DM had much less effect on its growth parameters (Figure 2) , indeed a slight reduction in lag phase was observed. We conclude that the lag-phase in the anchorage-dependent lines is unlikely simply to be the result of nutrient starvation.
The normal diploid human fibroblast line Flow 2002 grew extremely quickly in conventional culture, reaching confluence in 5 days (the DMEM/F12 formulation is generally regarded as being an optimal medium for fibroblast culture). There was no significant growth in the microcapsules over the 30-day observation period (Figure 3) , though there is a very slight upward trend. Their viability after this period was confirmed by disrupting the capsular membrane and releasing the cells into culture medium in flasks. They then grew with kinetics and morphology similar to those of standard monolayer preparations. Similar data were obtained using the mouse NIH3T3 fibroblast line (data not shown), indicating that the effect is not confined to the human fibroblast line we have chosen to study.
Cellular morphology
Microencapsulated human colorectal tumour cell lines grew in 3-dimensions (Figure 4 ). After the interior calcium alginate gel matrix had been dissolved in citrate, the majority of the cells sedimented to the trough of the hollow capsule (except those entrapped by the capsular membrane). Subsequent growth was in several clusters arising from aggregates of encapsulated cells. Fibroblasts also formed clumps, but these did not then expand.
Serial passage in microcapsules Serial passage of the tumour lines HT29 and COLO 320DM in microcapsules resulted in a significant reduction in the lag phase. This was observed after one passage and was most pronounced after two ( Figure 5 ). That for HT29 decreased from 10 days to 4 days and that for COLO 320DM from 3 days to 1 day. The doubling times remained essentially unaltered during the course of the experiment. Some evidence for a re-introduction of the lag phase was visible in the fourth passage ( Figure Sa) .
The cells were released into conventional culture after the fourth passage. The COLO 320DM cells continued to grow in clusters in suspension but HT29 cells grew initially as distinct colonies consisting of a central multilayered adherent cluster of cells from which peripheral cells migrated to cover the surface of the flask (data not shown).
MICROENCAPSULATED TUMOUR CELLS 677
Microencapsulated fibroblasts showed no significant growth in serial microcapsule passages (Figure 5c ). They remained viable however and when they were released from the fourth microcapsular passage, they grew in conventional culture, though initially with a tendency to form clumps. With further passage, they regained their original monolayer growth morphology (data not shown). Ultrastructure of encapsulated cells Microencapsulated cells were cultured for various periods and then processed for transmission electron microscopy. This revealed generally good cell viability ( Figure 6 ) even in cultures which had not begun to multiply (Figure 6a , HT115 substrate-dependent cells) and which would never grow (Figure 6c (Selby et al., 1983) . The Flow 2002 fibroblasts also grow at low efficiency in this medium (data not shown), suggesting a common mechanism of inhibition (though con- centration of autocrine growth-inhibitory substances within the capsules cannot yet be ruled out). However, microencapsulation provides much easier access to the cells in that macromolecules of MW up to about 60,000 freely diffuse across the membrane (Shimi et al., 1991) . In addition, the cells may be recovered and re-passaged or transferred to conventional culture. This will allow future experiments to determine which factors may promote fibroblast growth and to examine the molecular events required in the lag phase of tumour cell culture.
Electron microscopy demonstrates tight junctions between cells and some evidence of differentiation in microcapsular cultures. We have not yet examined this phenomenon in detail but ultrastructural studies of these cells growing in monolayers, semi-solid media and microcapsules are in progress. In the meantime, we are encouraged that some microcapsular cultures show properties similar to those of gastrointestinal epithelial cells in vivo.
In summary, we have demonstrated that established tumour cell lines, whether anchorage-dependent or anchorageindependent, can adapt rapidly to growth inside microcapsules. Three-dimensional structures are formed and electronmicroscopic features characteristic of intestinal epithelia can be observed. Microcapsular culture strongly selects against the proliferation of fibroblasts. We believe that this system will have significant advantages for the culture of primau human tumour material where these preparations of geo etry and selection will be important. In addition, by offering the possibility of switching between monolayer and threedimensional culture in vitro, it will be useful for the study of the relationship between geometry and expression of cell-cell adhesive properties and immunological markers of differentiation.
